比较 high-dose insulin 与血管加压药或联合治疗在猪难治性普萘洛尔诱导心源性休克模型中的随机对照研究
该研究为猪模型随机对照研究,15头猪随机分为HDI组、HDI+NE组和NE+Epi组,均接受普萘洛尔输注建立中毒模型。在主要毒性点(P1,HR×MAP下降25%)时HDI组和HDI+NE组接受HDI,NE+Epi组接受NE;当持续MAP<55 mmHg(P2)后,HDI组接受生理盐水,HDI+NE组接受NE,NE+Epi组接受Epi直至死亡或删失。结果显示HDI+NE组较单用HDI组更好地维持PtO2,三组平均生存时间分别为1.9、2.9和0.1小时;NE+Epi组因快速血流动力学崩溃无法分析PtO2数据。作者结论认为HDI+NE在MAP<55 mmHg时优于单用HDI维持PtO2,若最大化HDI后MAP仍持续<55 mmHg,应考虑加用NE。
要点
- 在猪难治性普萘洛尔诱导心源性休克模型中,HDI+NE组较单用HDI组更好地维持脑组织氧合(PtO2)。
- HDI组、HDI+NE组和NE+Epi组的平均生存时间分别为1.9、2.9和0.1小时。
- NE+Epi组因快速血流动力学崩溃,无法分析其PtO2数据。
- 从P2(持续MAP<55 mmHg)到死亡或删失的生存时间在HDI组与HDI+NE组间无差异。
- 作者认为若最大化HDI后MAP仍持续<55 mmHg,应考虑加用NE以维持PtO2。
适用人群与场景
- 猪难治性普萘洛尔诱导心源性休克模型,共15头猪。
诊断标准与关键阈值
- 主要毒性(P1)定义为心率(HR)乘以平均动脉压(MAP)下降25%。
- 持续MAP<55 mmHg定义为P2。
处置流程与药物剂量
- 在P1时,HDI组和HDI+NE组接受HDI,NE+Epi组接受NE。
- 在P2(持续MAP<55 mmHg)后,HDI组接受生理盐水(NS),HDI+NE组接受NE,NE+Epi组接受Epi,直至死亡或删失。
- 作者认为若最大化HDI后MAP仍持续<55 mmHg,应考虑加用NE以维持PtO2。
研究设计与关键结果
- 研究类型为随机对照动物实验,样本量15头猪,随机分为HDI组、HDI+NE组和NE+Epi组。
- HDI+NE组较单用HDI组更好地维持PtO2。
- HDI组、HDI+NE组和NE+Epi组的平均生存时间分别为1.9、2.9和0.1小时。
- NE+Epi组因快速血流动力学崩溃,无法分析PtO2数据。
- 从P2到死亡或删失的生存时间在HDI组与HDI+NE组间无差异。
证据类型、等级与局限
- 证据类型:随机对照动物实验(猪模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在猪难治性普萘洛尔诱导心源性休克模型中,当MAP持续<55 mmHg时,HDI+NE较单用HDI更好地维持PtO2。
- 作者认为若最大化HDI后MAP仍持续<55 mmHg,应考虑加用NE以维持PtO2。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Context: Although cerebral perfusion (CP) is preserved across a wide range of mean arterial pressures (MAP) through cerebral-vascular autoregulation, the relationship between MAP and CP in refractory poison-induced cardiogenic shock (PICS) has never been studied. We compared the effects of therapies used in PICS: high-dose insulin (HDI), HDI plus norepinephrine (NE), and vasopressors alone (NE plus epinephrine (Epi)) on cerebral tissue oxygenation (PtO2). Methods: Fifteen swine were randomized to either HDI, HDI + NE, or NE + Epi. All animals received a propranolol infusion using an established model of toxicity. At primary toxicity (P1), defined as a 25% reduction in heart rate (HR) multiplied by MAP, the HDI and HDI + NE groups received HDI and the NE + Epi group received NE. Once a sustained MAP < 55 mmHg was reached (P2), the HDI group received saline (NS), the HDI + NE group received NE and the NE + Epi group received Epi until death or censoring. PtO2 and hemodynamic parameters including MAP, cardiac output (CO) and central venous pressure (CVP) were measured every 10 minutes. Glucose and potassium were measured at predetermined intervals. Results: Animals treated with HDI + NE maintained PtO2 over time more than the HDI-alone group. Due to rapid hemodynamic collapse, we were unable to analyze PtO2 data in the vasopressor only animals. Mean survival time was 1.9, 2.9 and 0.1 hours for the HDI, HDI + NE and NE + Epi groups, respectively. Survival time from P2 (sustained MAP <55 mmHg) to death or censoring was not different between HDI and HDI + NE groups. Conclusions: HDI + NE treatment was superior to HDI-alone at preserving PtO2 when MAP < 55 mmHg. We were unable to compare the PtO2 between the NE + Epi to the HDI or HDI + NE due to rapid decline in CO and death. If MAP is sustained at < 55 mmHg after maximizing HDI, adjunctive treatment with NE should be considered to preserve PtO2.
参考来源
- Katzung KG, Leroy JM, Boley SP, et al. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock. Clin Toxicol (Phila). 2019. PMID: 30806099. doi:10.1080/15563650.2019.1580372
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。